共 31 条
- [21] Lassmann H., Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease, J. Neural Transm., 118, pp. 747-752, (2011)
- [22] Mesaros S., Rocca M.A., Riccitelli G., Et al., Corpus callosum damage and cognitive dysfunction in benign multiple sclerosis, Human Brain Mapping, 30, pp. 2656-2666, (2009)
- [23] Moffett J.R., Namboodiri M.A.A., Cangro C.B., Neale J.H., Immunohistochemical localization on N-acetylaspartate in rat brain, Neuroreport, 2, pp. 131-134, (1991)
- [24] Narayana P.A., Wolinsky J.S., Rao S.B., Et al., Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis, Mult. Scler., 10, pp. 73-78, (2004)
- [25] Rimkus C.M., Jungueira T.F., Lyra K., Et al., Corpus callosum microstructural changes correlate with cognitive dysfunction of early stages of relapsing-remitting multiple sclerosis: Axial and radial diffusivities, Mult. Scler. Int., pp. 7-15, (2011)
- [26] Sajja B.R., Narayana P.A., Wolinsky J.S., Et al., Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: Multicentre study, Mult. Scler., 14, pp. 73-80, (2008)
- [27] Sajja B.R., Wolinsky J.S., Narayanna P.A., Proton magnetic resonance spectroscopy in multiple sclerosis, Neuroimaging Clin. N. Am., 19, pp. 45-58, (2009)
- [28] Sijens P.E., Mostert J.P., Oudkerk M., Et al., (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: Initial findings, Eur. Radiol., 16, 2, pp. 489-495, (2006)
- [29] Simmons M.L., Frondoza C.G., Coyle J.T., Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies, Neurosci., 45, pp. 37-45, (1991)
- [30] Stadelmann C., Albert M., Wegner C., Et al., Curr. Opin. Neurol., 21, pp. 229-234, (2008)